ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.

Every day two or three Canadians die of the disease.

Learn More About ALS

 Support an ALS EventEvents CalendarHealthcare ProvidersClinical TrialsALS and Youth





ALS News

WALK for ALS early results: $3.9 million (and counting!) raised nationwide

Throughout the spring, summer and fall of 2016, Canadians showed they care about beating ALS, the devastating neuromuscular disease that gradually paralyzes people and takes away their ability to move, talk, swallow, eat and eventually breathe.

Our hearts are heavy as we say good-bye to Mauril Bélanger, MP for Ottawa-Vanier. Diagnosed with ALS in late 2015, he partnered with the ALS Societies across Canada and took on the role of National Honorary Spokesperson for the 2016 WALK for ALS.

“Every August until a cure. Because we have to.”

These words from Ice Bucket Challenge co-founder Pat Quinn speak to the importance of raising money for ALS research. As we approach the second anniversary of the Ice Bucket Challenge, we are already seeing its impact: last week, researchers who were funded through Ice Bucket Challenge donations announced that the gene NEK1 has been found to play a role in the development of ALS.

July 28, 2016 – Earlier this week researchers announced that the gene NEK1 has been found to play a significant role in the development of amyotrophic lateral sclerosis (ALS). This landmark discovery is the result of an 11-country research collaboration that was funded through the Ice Bucket Challenge. The research team included 3 Canadians, one of whom was directly funded by the ALS Society of Canada for their work during this discovery.

MARKHAM, ON, April 19, 2016 /CNW/ - Six months ago, Liberal MP Mauril Bélanger was running in the federal election, continuing his dedication of over 20 years to serving his constituents in the riding of Ottawa-Vanier. His life changed November 2015, when he was diagnosed with the terminal disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's. Although ALS has taken away his ability to speak, it has not taken away his voice or commitment to help others.

First ALS Canada Clinical Management Grant to Support Exploration of Cannabinoids on Quality of Life